Daniel E Cohen Selected Research

Daniel E Cohen Research Topics

18	Infections 01/2021 - 08/2006
8	Fibrosis (Cirrhosis) 12/2020 - 01/2014
5	Chronic Hepatitis C 01/2019 - 07/2013
4	Acquired Immunodeficiency Syndrome (AIDS) 04/2021 - 03/2008
4	Coinfection 01/2020 - 06/2003
3	HIV Infections (HIV Infection) 04/2021 - 01/2020
3	Hepatitis C 01/2020 - 01/2013
3	Chronic Renal Insufficiency 02/2019 - 06/2016
2	Kidney Diseases (Kidney Disease) 02/2019 - 02/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 02/2019 - 06/2016
2	Anemia 01/2018 - 06/2016
1	Virus Diseases (Viral Diseases) 01/2021
1	Substance-Related Disorders (Drug Abuse) 12/2020
1	Mental Disorders (Mental Disorder) 12/2020
1	Liver Diseases (Liver Disease) 02/2019
1	Hemolytic Anemia 01/2018
1	Viremia 03/2015
1	Body Weight (Weight, Body) 01/2014
1	Disease Progression 03/2007
1	Acute-Phase Reaction 07/2004

19	paritaprevirIBA 12/2020 - 01/2013
18	Ritonavir (Norvir)FDA Link 12/2020 - 01/2013
17	ombitasvirIBA 12/2020 - 01/2014
16	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2013
16	dasabuvirIBA 12/2020 - 01/2013
15	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 01/2013
7	InterferonsIBA 01/2019 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2013
2	EpitopesIBA 03/2007 - 07/2004
1	HLA-DR Antigens (HLA-DR)IBA 04/2021
1	Human immunodeficiency virus 1 p16 proteaseIBA 01/2020
1	Raltegravir Potassium FDA Link 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Lipopolysaccharide ReceptorsIBA 01/2020
1	Cytochrome P-450 CYP2B1 (PROD)IBA 01/2020
1	SofosbuvirIBA 01/2019
1	QuartzIBA 01/2019
1	ledipasvirIBA 01/2019
1	Inosine TriphosphataseIBA 01/2018
1	TabletsIBA 01/2017
1	Erythropoietin FDA Link 06/2016
1	Clindamycin (Cleocin)FDA LinkGeneric 02/2008
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2007
1	HLA-A3 Antigen (HLA A3 Antigen)IBA 07/2004
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2003

11	Therapeutics 04/2021 - 02/2007
2	Duration of Therapy 01/2020 - 01/2017
1	Renal Dialysis (Hemodialysis) 06/2016
1	Highly Active Antiretroviral Therapy (HAART) 03/2008
1	Ambulatory Care (Outpatient Care) 08/2006